| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/05/1996 | EP0714281A1 Deodorant composition containing tonalide |
| 06/04/1996 | US5523089 Borrelia antigen |
| 05/29/1996 | EP0713915A1 Hog cholera virus vaccine and diagnostic |
| 05/29/1996 | EP0713520A1 Fragrance and deodorant composition containing said fragrance |
| 05/29/1996 | EP0713388A1 A method for high loading of vesicles with biopolymeric substances |
| 05/29/1996 | CN1123176A A process for the preparation of pesticide-poor concentrates of active components of plants |
| 05/29/1996 | CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication |
| 05/28/1996 | US5520926 Wound dressings |
| 05/23/1996 | WO1996015106A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 05/23/1996 | WO1996014846A1 Dihydropyrimidines and uses thereof |
| 05/22/1996 | EP0712401A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives |
| 05/22/1996 | EP0712400A1 Novel substituted benzimidazoles |
| 05/22/1996 | EP0712309A1 Hair styling compositions containing a silicone grafted polymer and low level of a volatile hydrocarbon solvent |
| 05/22/1996 | EP0454735B1 Vaccine composition |
| 05/22/1996 | CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
| 05/21/1996 | US5518647 Foaming liquid emulsion composition |
| 05/17/1996 | WO1996014326A1 Antifungal sordaridin derivatives |
| 05/17/1996 | WO1996014058A1 Melt-extruded orally administrable opioid formulations |
| 05/17/1996 | CA2179403A1 Antifungal sordaridin derivatives |
| 05/15/1996 | EP0711771A2 Substituted-1,3-oxathiolanes with antiviral properties |
| 05/15/1996 | EP0711563A1 Novel Borrelia vaccine |
| 05/15/1996 | EP0711154A1 Stabilized pharmaceutical composition containing bupropion |
| 05/15/1996 | CN1122226A Tablet, capsule, or granule comprising desogestrel |
| 05/14/1996 | US5516457 Ultraviolet absorbing compositions |
| 05/14/1996 | CA1338326C Compounds for the treatment of alzheimer's disease |
| 05/09/1996 | WO1996013273A1 Pharmaceutical compositions |
| 05/08/1996 | EP0580648B1 Process for conditioning of water-soluble substances |
| 05/08/1996 | EP0517778B1 Vasoactive vasotocin derivatives |
| 05/08/1996 | EP0365646B1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 05/07/1996 | US5514680 Glycine receptor antagonists and the use thereof |
| 05/07/1996 | CA2014157C Antiparasitic formulation containing 25-cyclohexyl-avermectin b1 |
| 05/02/1996 | WO1996012737A2 Compositions and treatment for multiple sclerosis |
| 05/02/1996 | WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 05/02/1996 | CA2203629A1 Compositions and treatment for multiple sclerosis |
| 05/01/1996 | EP0708634A1 Dyes containing tetraaminopyrimidine and direct-dyeing agents |
| 05/01/1996 | EP0708632A1 High lathering anti-dandruff shampoos |
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 04/30/1996 | US5512556 For the prevention and treatment of mammary tumors |
| 04/25/1996 | WO1996011692A1 Use of anthocyanidin and derivatives for treatment of retroviral infections |
| 04/25/1996 | CA2202467A1 Use of anthocyanidin and derivatives for treatment of retroviral infections |
| 04/24/1996 | EP0707584A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
| 04/24/1996 | EP0707580A1 Magnesium omeprazole |
| 04/24/1996 | EP0707572A1 Iodinated oligomeric compounds and diagnostic compositions containing the same |
| 04/24/1996 | EP0707479A1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 04/23/1996 | US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders |
| 04/18/1996 | WO1996011191A1 Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis |
| 04/17/1996 | EP0706797A2 Compositions containing carbohydrates obtained from plants of the family cactacea |
| 04/17/1996 | EP0706395A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 04/16/1996 | US5508307 Administering lithium salts of fatty acids intravenously, monitoring plasma lithium levels to avoid hemolysis |
| 04/16/1996 | US5508043 Sodium alginate and a calcium salt which crosslinks with the alginate when exposed to aqueous solutions; administered orally with a higher aliphatic alcohol |
| 04/16/1996 | US5508042 Administering an oral dosage every 12 hours |
| 04/16/1996 | US5508024 Topical antiperspirant composition consisting essentially of non-toxic water-insoluble occlusive film-forming antiperspirant polymer |
| 04/10/1996 | EP0705245A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 04/10/1996 | EP0705102A1 Use of corrinoids in topical treatment of skin diseases |
| 04/10/1996 | EP0705094A1 Skin and scalp barrier for use with hair treatment products |
| 04/09/1996 | US5506214 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/09/1996 | US5506213 Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease |
| 04/09/1996 | US5505935 Ethylene-vinyl acetate copolymer, acrylic polymer, sunscreen agent |
| 04/04/1996 | WO1996010027A1 N-substituted piperidinyl bicyclic benzoate derivatives |
| 04/04/1996 | WO1996009840A1 Contrast agent |
| 04/03/1996 | EP0703774A1 High foaming oral composition |
| 04/03/1996 | CN1119827A Non-aerosol shaving gel |
| 04/02/1996 | US5503847 Hydrocolloid wound gel |
| 03/28/1996 | WO1996009033A1 Granular compositions |
| 03/27/1996 | EP0702719A1 Process for the sterilization of biological compositions and the product produced thereby |
| 03/27/1996 | EP0702555A1 Pyrazolopyrimidinones for the treatment of impotence |
| 03/27/1996 | EP0448644B1 Transdermal estrogen/progestin dosage unit and system. |
| 03/27/1996 | CN1119098A Sunning protecting cosmetic composition based on light filing agent efficiency increasing mixture and use of same |
| 03/26/1996 | US5502045 Use of a stanol fatty acid ester for reducing serum cholesterol level |
| 03/21/1996 | WO1996008489A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 03/20/1996 | EP0701813A2 Oil-in-water emulsion containing a fragrance |
| 03/20/1996 | CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines |
| 03/19/1996 | US5500359 Fermentation, antitumor agents |
| 03/19/1996 | US5500227 Immediate release tablet cores of insoluble drugs having sustained-release coating |
| 03/19/1996 | US5500210 Combined two-part reducing agent/humectant shaving system for improved shaving comfort |
| 03/19/1996 | US5500022 Process for dyeing keratinous fibres with 2,6-dimethyl-1,4-diaminobenzene and/or 2,3-dimethyl-1,4-diaminobenzene and/or 2,6-diethyl-1,4-diaminobenzene in an acid medium and compositions employed |
| 03/14/1996 | WO1996007413A1 Compounds and methods for the treatment of cancer |
| 03/14/1996 | WO1996002229A3 Soap composition |
| 03/14/1996 | DE19517981A1 Prodn. of permanent wave in hair |
| 03/13/1996 | EP0455783B1 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
| 03/12/1996 | CA2046943C Process for producing an agent with the active substance flupirtine to combat muscular tension |
| 03/07/1996 | WO1996006594A1 Topically-effective compositions |
| 03/07/1996 | WO1995032291A3 Hepatitis g virus and molecular cloning thereof |
| 03/07/1996 | CA2198227A1 Topically-effective compositions |
| 03/06/1996 | EP0699436A1 Controlled release formulation |
| 03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
| 03/06/1996 | EP0699073A1 Allogeneic and xenogeneic transplantation |
| 03/06/1996 | EP0587723B1 Quinuclidine derivatives |
| 03/05/1996 | US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it |
| 02/29/1996 | CA2197466A1 Compositions |
| 02/28/1996 | EP0698389A1 Controlled release matrix for pharmaceuticals |
| 02/28/1996 | EP0660699A4 Hair relaxer compositions. |
| 02/28/1996 | CN1117712A Extract from flowers of salvia officinalis, process for its preparation and use thereof |
| 02/27/1996 | US5494900 UDPG as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without BAU |
| 02/22/1996 | WO1996004913A1 Hiv protease inhibitor combination |
| 02/22/1996 | WO1996001110A3 Anti-hiv triple combination |
| 02/22/1996 | WO1996000068A3 Combination therapy for hiv infection |
| 02/21/1996 | CN1116924A Utilisation des acides sulfoniques comme agents antivieillissement dans une composition cosmetiqueou dermatologique |
| 02/18/1996 | CA2156120A1 3-substituted-2-oxindoles as inhibitors of viral replication |
| 02/17/1996 | CA2156197A1 Composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals |